Knee Resurfacing Implant
Development- Indications
- Knee reconstruction
Company intelligence / Profile preview
Artimplant developed and commercialized degradable implants based on its proprietary Artelon® polymer for orthopedic applications. The company received FDA approval for several products including surgical sutures and rotator cuff implants. However, following litigation related to product safety in the US and financial difficulties, it filed for bankruptcy in August 2013. Products were previously marketed globally through distributors and licensees.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Artimplant.